Kaplan-Meier Statistics to Estimate Treatment Success: Response

Affiliations

¹ Santhera Pharmaceuticals, Pratteln, Switzerland , Santhera Pharmaceuticals, Pratteln, Switzerland, Department of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-University, Munich, Germany, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

Comment

Magda Silva et al. J Neuroophthalmol. 2023.

. 2023 Dec 1;43(4):e361-e362.

doi: 10.1097/WNO.0000000000001628. Epub 2022 May 24.

¹ Santhera Pharmaceuticals, Pratteln, Switzerland , Santhera Pharmaceuticals, Pratteln, Switzerland, Department of Neurology, Friedrich-Baur-Institute, University Hospital of the Ludwig-Maximilians-University, Munich, Germany, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.

No abstract available

Comment on

Kaplan-Meier Statistics to Estimate Treatment Success.
Wubbels RJ. Wubbels RJ. J Neuroophthalmol. 2023 Dec 1;43(4):e360-e361. doi: 10.1097/WNO.0000000000001627. Epub 2022 Jun 14. J Neuroophthalmol. 2023. PMID: 36166805 No abstract available.

1. Catarino C, von Livonius B, Priglinger C, Banik R, Matloob S, Tamhankar MA, Castillo L, Friedburg C, Halfpenny CA, Lincoln JA, Traber GL, Acaroglu G, Black GCM, Doncel C, Fraser CL, Jakubaszko J, Landau K, Langenegger SJ, Muñoz-Negrete FJ, Newman NJ, Poulton J, Scoppettuolo E, Subramanian P, Toosy AT, Vidal M, Vincent AL, Votruba M, Zarowski M, Zermansky A, Lob F, Rudolph G, Mikazans O, Silva M, Llòria X, Metz G, Klopstock T. Real-world clinical experience with idebenone in the treatment of leber hereditary optic neuropathy. J Neuroophthalmol. 2020;40:558–565.